Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Ketorolac for Morphine Dose Escalation
NCT00349401Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Dec 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ketorolac in neuropathic pain, sponsored by Wake Forest University Health Sciences. Planned start Dec 2006; status: withdrawn.
02
Drugs
ketorolac
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00349401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349401.